Chiron Real Estate: From High-Teens To Sub-10x FFO, A Rebound Case

Luuk Wierenga1.5K FollowersFollow5ShareSavePlay(14min)CommentsSummaryChiron Real Estate is rated a 'buy' due to a significant margin of safety versus intrinsic value and a compelling 8.5% monthly dividend yield.XRN's portfolio is diversified across healthcare assets, with manageable tenant and geographic concentration; no major refinancing risk exists until after 2027.At $35.24, XRN trades at ~9x FFO, well below its historical multiple and 32% below intrinsic value, offering a conservative total return expectation of 10.6%.High leverage increases sensitivity to interest rates, but management alignment and recent insider buying reinforce conviction in undervaluation and future upside. 10'000 Hours/DigitalVision via Getty Images Introduction As a (contrarian) REIT investor, I solely cover REITs on Seeking Alpha. Preferably REITs that are disliked by the market and are undervalued beyond what I deem to be reasonable. Today I wantThis article was written byLuuk Wierenga1.5K FollowersFollowI'm Luuk Wierenga, an economics teacher from the Netherlands with a strong passion for income investing. My investment journey began during the COVID-19 pandemic, and since then, I've specialized in identifying Real Estate Investment Trusts (REITs) that are temporarily out-of-favor with Mr. Market. As an educator, I use fundamental economic insights to assess the true intrinsic value of a stock. My investment horizon is long-term, and my strategy revolves around contrarian and deep-value opportunities.Analyst’s Disclosure: I/we have a beneficial long position in the shares of XRN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.